Incorporating yoga as a complementary therapy to standard pharmacological treatment of migraine helps reduce the frequency and intensity of migraine and its impact on the lives of people with such condition, according to the CONTAIN* study presented at the 2019 AHS Meeting.
A recent analysis of 1,289 individuals across normal, overweight and obese Body Mass Index (BMI) ranges demonstrated that higher BMI and waist circumference values were significantly associated with thinner brain cortices.
A recently published prospective cohort study involving 2,000 individuals ≥70 years of age demonstrated that engaging in mentally stimulating activities, such as computer use, social and craft activities and playing games, was associated with a decreased risk of mild cognitive impairment (MCI).
New drug applications approved by US FDA as of 16 - 31 July 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Having supportive family relationships may help youth maintain good asthma management behaviours despite difficult neighbourhood conditions--thus serving as a buffer against poor asthma outcomes associated with living in disorderly neighbourhoods, a recent study finds.
People who died by suicide on their first attempt tended to be male, older, to use lethal methods and die in the context of specific stressful life circumstances, as reported in a recent study aimed at helping identify more individuals at risk of suicide.
More than three-fourths of people with mood, anxiety and alcohol use disorder in Singapore receive no treatment for their condition, reflecting a high treatment gap in mental healthcare that has remained a matter of concern for years now, according to data from the 2016 Singapore Mental Health Study.
Nurses who undergo an educational training intervention on rapid tranquilization usage have had improved knowledge and confidence in dealing with patient violence in hospitals, in addition to the safe practice of such procedure, according to a Singapore study.
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.